In a report published Friday, Wunderlich Securities downgraded its rating on Medtronic MDT from Buy to Hold, and reiterated its $46.00 price target.
Wunderlich Securities noted, “We are downgrading the shares of Medtronic (MDT) from Buy to Hold, as the shares have exceeded our $46 price target. We continue to view Medtronic favorably as an attractive total return vehicle for investors, and the central element of our investment thesis - a developing new product story - continues to take shape and should become increasingly visible in 2014 and beyond. But with MDT shares up 13% in the first three weeks of January and above our price target, we take a more neutral position on the shares at this point. We continue to view MDT as a high quality MedTech player and attractive total return vehicle, but would be more constructive on the name in the low $40s.”
Medtronic closed on Thursday at $46.45.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in